Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy

NCT03068702 is registered in ClinicalTrials.gov with Dr. S.S. Michel Clinic as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03068702 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA): Sickle Cell Maculopathy
Lead sponsor
Dr. S.S. Michel Clinic
Phase
Observational
Overall status
Completed
Start date
August 21, 2016
Completion date
February 21, 2017
Enrollment
2 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell retinopathy